ARCHIVES

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

This article is from The Cancer Letter archive.

Vol. 21 No. 43 | November 10, 1995

Download PDF Visit The Full Archive

Related Articles

NSABP Operations Office Moves Across Town To Allegheny

December 13, 1996

BRCA Status Can Guide Ovarian Cancer Treatment

April 25, 2008

RFP, RFA Available

March 26, 1993

FDA Hazleton Probe Finds Some Problems; Results Unaffected

April 23, 1976

Pittsburgh Cancer Institute Gets NCI Core Grants

June 24, 1988

Fox Chase Forms Network Of Oncologists

February 9, 1996